VivoSeq
Oncology

Testicular Cancer

0

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Testicular Cancer is an early-stage landscape with 0 programs across 1 company. The most active players are BioNTech.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

BioNTech logo

BioNTech

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed5 · 45%
Recruiting2 · 18%
Not yet recruiting2 · 18%
Withdrawn1 · 9%
Active, not recruiting1 · 9%

Clinical Trials

Trial Activity

11 trials

THERApy De-escalation for TESTicular Cancer
Recruiting·QQueen Mary University of London·N/A·NCT06309745·30 enrolled
Patient Reported Experiences With Sparing ExteRnal Oblique Fascia Vs Standard Inguinal OrchiEctomy
Recruiting·LLoma Linda University·Preclinical·NCT06828185·80 enrolled
Phase II Study of Effectiveness of Using Low-dose CT in Patient Undergoing Surveillance for Clinical Stage I Testicular Cancer
Active, not recruiting·UUniversity Health Network, Toronto·Preclinical·NCT03142802·251 enrolled
RAISN 2: Prospective Randomized Trial of Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care
Not yet recruiting·HHeinrich-Heine University, Duesseldorf·Preclinical·NCT07699640·171 enrolled
Virtual Testicular Cancer Lay Support and Survivorship (VITALSS Study) Aim 2
Not yet recruiting·UUNC Lineberger Comprehensive Cancer Center·Preclinical·NCT06702592·360 enrolled
Short-term Testosterone Replacement in Testicular Cancer Survivors
Completed·UUniversity Medical Center Groningen·Phase 2·NCT03339635·32 enrolled
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
Completed·MMedical Research Council·Phase 2·NCT00004077·25 enrolled
Study of Testosterone vs Placebo in Testicular Cancer Survivors
Completed·—·Phase 2/3·NCT02991209·69 enrolled
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
Completed·MMedical Research Council·Phase 3·NCT00003014·800 enrolled
A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Completed·UUniversity of Southern California·Phase 2·NCT00183820·30 enrolled
A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm
Withdrawn·BioNTech logoBioNTech·Phase 2·NCT06940804

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)